Consolidated Portfolio Review Corp Has $581,000 Stake in BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Consolidated Portfolio Review Corp lowered its holdings in BlackRock Capital Allocation Term Trust (NYSE:BCAT) by 2.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 35,347 shares of the company’s stock after selling 934 shares during the quarter. Consolidated Portfolio Review Corp’s holdings in BlackRock Capital Allocation Term Trust were worth $581,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of BCAT. Truist Financial Corp acquired a new position in shares of BlackRock Capital Allocation Term Trust during the second quarter valued at about $319,000. Ironsides Asset Advisors LLC boosted its stake in BlackRock Capital Allocation Term Trust by 14.1% during the 1st quarter. Ironsides Asset Advisors LLC now owns 29,133 shares of the company’s stock valued at $485,000 after purchasing an additional 3,606 shares during the last quarter. Oppenheimer & Co. Inc. increased its holdings in BlackRock Capital Allocation Term Trust by 18.6% during the 1st quarter. Oppenheimer & Co. Inc. now owns 29,180 shares of the company’s stock worth $486,000 after purchasing an additional 4,586 shares in the last quarter. Claro Advisors LLC raised its stake in shares of BlackRock Capital Allocation Term Trust by 101.3% in the third quarter. Claro Advisors LLC now owns 31,734 shares of the company’s stock worth $522,000 after purchasing an additional 15,969 shares during the last quarter. Finally, Almitas Capital LLC bought a new position in shares of BlackRock Capital Allocation Term Trust in the second quarter valued at approximately $728,000. Institutional investors own 36.12% of the company’s stock.

Insider Activity

In related news, major shareholder Saba Capital Management, L.P. sold 15,894 shares of the business’s stock in a transaction dated Tuesday, September 17th. The shares were sold at an average price of $16.41, for a total transaction of $260,820.54. Following the transaction, the insider now directly owns 16,317,706 shares in the company, valued at approximately $267,773,555.46. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders sold a total of 723,927 shares of company stock worth $11,925,047 over the last quarter.

BlackRock Capital Allocation Term Trust Stock Down 0.1 %

Shares of NYSE:BCAT opened at $16.10 on Friday. The business’s 50 day moving average is $16.38 and its 200 day moving average is $16.25. BlackRock Capital Allocation Term Trust has a 12-month low of $13.70 and a 12-month high of $17.18.

BlackRock Capital Allocation Term Trust Increases Dividend

The company also recently announced a monthly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th will be paid a $0.2871 dividend. This is a positive change from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10. The ex-dividend date of this dividend is Tuesday, October 15th. This represents a $3.45 annualized dividend and a dividend yield of 21.40%.

BlackRock Capital Allocation Term Trust Profile

–